Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4196 - 4196
Abstract Background: R/R DLBCL remains an area of unmet medical need and treatments with novel mechanisms of action are urgently needed. Germinal center DLBCLs...
Journal Article
Blood, ISSN 0006-4971, 01/2018, Volume 131, Issue 2, pp. 174 - 181
The benefit of radiotherapy (RT) after chemotherapy in limited-stage diffuse large B-cell lymphoma (DLBCL) remains controversial. We conducted a randomized...
TRIAL | SOUTHWEST-ONCOLOGY-GROUP | RITUXIMAB | PLUS RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | LOCALIZED AGGRESSIVE LYMPHOMA | INVOLVED-FIELD RADIOTHERAPY | HEMATOLOGY | ELDERLY-PATIENTS | CHEMOTHERAPY | RADIATION-THERAPY | Clinical Trials and Observations
TRIAL | SOUTHWEST-ONCOLOGY-GROUP | RITUXIMAB | PLUS RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | LOCALIZED AGGRESSIVE LYMPHOMA | INVOLVED-FIELD RADIOTHERAPY | HEMATOLOGY | ELDERLY-PATIENTS | CHEMOTHERAPY | RADIATION-THERAPY | Clinical Trials and Observations
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4426 - 4426
Abstract The T3 trial is a multicenter Phase IB dose escalation study that evaluates the safety, feasibility and efficacy of three Temsirolimus-based...
Journal Article
Bioinformatics, ISSN 1367-4803, 02/2011, Volume 27, Issue 3, pp. 419 - 420
The use of high-density SNP arrays for investigating copy number alterations in clinical tumor samples, with intra tumor heterogeneity and varying degrees of...
COPY-NUMBER | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | RESOLUTION | BIOCHEMICAL RESEARCH METHODS | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Algorithms | Neoplasms - genetics | Oligonucleotide Array Sequence Analysis - methods | Humans | Polymorphism, Single Nucleotide | Software | Genomics - methods
COPY-NUMBER | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | RESOLUTION | BIOCHEMICAL RESEARCH METHODS | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Algorithms | Neoplasms - genetics | Oligonucleotide Array Sequence Analysis - methods | Humans | Polymorphism, Single Nucleotide | Software | Genomics - methods
Journal Article
Brain Injury, ISSN 0269-9052, 2008, Volume 22, Issue 10, pp. 786 - 792
Primary objective: The aim of the present study was to explore the concurrent validity, inter-rater agreement and diagnostic sensitivity of a French adaptation...
neurobehavioural | closed head injury | Vegetative state | minimally conscious state | Minimally conscious state | Closed head injury | Neurobehavioural | DIAGNOSIS | SENSORY MODALITY ASSESSMENT | BRAIN-DAMAGE | NEUROSCIENCES | vegetative state | ACCURACY | WESSEX HEAD-INJURY | REHABILITATION TECHNIQUE | PERSISTENT VEGETATIVE STATE | REHABILITATION | PATIENT | MISDIAGNOSIS | Diagnosis, Differential | Brain Damage, Chronic - diagnosis | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Consciousness - physiology | Trauma Severity Indices | Coma - diagnosis | Brain Injuries - diagnosis | Monitoring, Physiologic | Language | Persistent Vegetative State - diagnosis | Sensitivity and Specificity | Aged, 80 and over | Recovery of Function - physiology | Adult | Female | Aged | Observer Variation
neurobehavioural | closed head injury | Vegetative state | minimally conscious state | Minimally conscious state | Closed head injury | Neurobehavioural | DIAGNOSIS | SENSORY MODALITY ASSESSMENT | BRAIN-DAMAGE | NEUROSCIENCES | vegetative state | ACCURACY | WESSEX HEAD-INJURY | REHABILITATION TECHNIQUE | PERSISTENT VEGETATIVE STATE | REHABILITATION | PATIENT | MISDIAGNOSIS | Diagnosis, Differential | Brain Damage, Chronic - diagnosis | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Consciousness - physiology | Trauma Severity Indices | Coma - diagnosis | Brain Injuries - diagnosis | Monitoring, Physiologic | Language | Persistent Vegetative State - diagnosis | Sensitivity and Specificity | Aged, 80 and over | Recovery of Function - physiology | Adult | Female | Aged | Observer Variation
Journal Article
Hematological Oncology, ISSN 0278-0232, 06/2017, Volume 35, Issue S2, pp. 128 - 129
Journal Article
Astrophysical Journal, ISSN 0004-637X, 01/2012, Volume 745, Issue 1, pp. 1 - 16
We analyze data from the Solar and Heliospheric Observatory to produce global maps of coronal outflow velocities and densities in the regions where the solar...
Sun: corona | techniques: spectroscopic | solar wind | Coronas | Maps | Coronal holes | Flux | Outflow | Tubes | Solar wind | Density | ACCELERATION | SOLAR WIND | ASTROPHYSICS, COSMOLOGY AND ASTRONOMY | SPECTROMETERS | ULTRAVIOLET RADIATION | SOLAR CYCLE | SUN | VISIBLE RADIATION
Sun: corona | techniques: spectroscopic | solar wind | Coronas | Maps | Coronal holes | Flux | Outflow | Tubes | Solar wind | Density | ACCELERATION | SOLAR WIND | ASTROPHYSICS, COSMOLOGY AND ASTRONOMY | SPECTROMETERS | ULTRAVIOLET RADIATION | SOLAR CYCLE | SUN | VISIBLE RADIATION
Journal Article
BMC Cancer, ISSN 1471-2407, 04/2015, Volume 15, Issue 1, p. 288
Background: Adherence to therapy has been established for years as a critical parameter for clinical benefit in medical oncology. This study aimed to assess,...
Non-medical determinant of health | Relative dose-intensity | Treatment adherence | Overall survival | Lymphoma | RANDOMIZED CONTROLLED-TRIAL | CHEMOTHERAPY PLUS RITUXIMAB | BREAST-CANCER | ONCOLOGY | PREDICTORS | NONADHERENCE | NON-HODGKINS-LYMPHOMA | RELATIVE DOSE INTENSITY | PROGNOSTIC-SIGNIFICANCE | INDEX | ELDERLY-PATIENTS | Doxorubicin - therapeutic use | Humans | Middle Aged | Male | Cyclophosphamide - therapeutic use | Socioeconomic Factors | Aged, 80 and over | Adult | Female | France | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Comorbidity | Mortality | Kaplan-Meier Estimate | Treatment Outcome | Medication Adherence | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Large B-Cell, Diffuse - epidemiology | Vincristine - therapeutic use | Aged | Neoplasm Staging | Longitudinal Studies | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Care and treatment | Anthracyclines | Lymphomas | Diagnosis | Health aspects | Medicine, Experimental | Medical research | Analysis | Life Sciences
Non-medical determinant of health | Relative dose-intensity | Treatment adherence | Overall survival | Lymphoma | RANDOMIZED CONTROLLED-TRIAL | CHEMOTHERAPY PLUS RITUXIMAB | BREAST-CANCER | ONCOLOGY | PREDICTORS | NONADHERENCE | NON-HODGKINS-LYMPHOMA | RELATIVE DOSE INTENSITY | PROGNOSTIC-SIGNIFICANCE | INDEX | ELDERLY-PATIENTS | Doxorubicin - therapeutic use | Humans | Middle Aged | Male | Cyclophosphamide - therapeutic use | Socioeconomic Factors | Aged, 80 and over | Adult | Female | France | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Comorbidity | Mortality | Kaplan-Meier Estimate | Treatment Outcome | Medication Adherence | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Large B-Cell, Diffuse - epidemiology | Vincristine - therapeutic use | Aged | Neoplasm Staging | Longitudinal Studies | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Care and treatment | Anthracyclines | Lymphomas | Diagnosis | Health aspects | Medicine, Experimental | Medical research | Analysis | Life Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At...
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article